5444W-13 Teriparatide and Risedronate in the Treatment of Patients with Severe Postmenopausal Osteop

Teriparatide and Risedronate in the Treatment of Patients with Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures.

Type of Study
Rheumatology - Osteoporosis
Short Description

The purpose of this study is to evaluate if a daily subcutaneous medication is superior in reducing the incidence of new vertebral fractures compared with a weekly oral medication.

Status
Open
Principal Investigator
Christopher Shuhart, MD, MHA
Eligibility Notes
  • Must be a postmenopausal woman age 45 or older with vertebral fractures.
  • Must be willing to cooperate with the study's schedule of events.
Start Date
10/21/2013
Contact Name
Allison Everett
Phone
206-386-3201
Email
allison.everett@swedish.org